Immunogenicity Advisor and EU/Asia Business
B2S Life Sciences
Franklin, Indiana
Hisanori has almost 30 years of experience in regulated bioanalysis in biopharmaceutical PK, biomarkers and immunogenicity as well as small molecules at various positions in Japan and in Switzerland. He is a member of AAPS as well as a member of steering committee of JBF (Japan Bioanalysis Forum).
He currently serves as Immunogenicity Advisor and EU/Asia Business at B2S Life Sciences. He contributes to immunogenicity related documents, e.g. immunogenicity cut point reports, immunogenicity risk assessment, ISI (integrated summary of immunogenicity) etc in his role at B2S. B2S specializes in the generation and characterization of critical reagents to support regulated bioanalysis, provides R&D services for biotherapeutic drug candidates, offers bioanalytical and statistical support for immunogenicity, conducts quantitation of novel biomarkers, and provides data analytics and PK-PD analysis for biotherapeutics and investigations of drug delivery.
He is passionate about contributing more to new approaches in immunogenicity assessment.
Disclosure information not submitted.
Systematic Assessment of S/N Ratios as Alternative for ADA Titers
Tuesday, July 15, 2025
8:35 AM - 9:05 AM ET
Beyond the Analysis: Immunogenicity and Beyond: Panel Discussion
Tuesday, July 15, 2025
11:05 AM - 11:55 AM ET